As a main objective – identify and functionally evaluate genes potentially associated with CHD/HLHS – our study highlights rare, predicted-damaging LRP2 missense variants as 3-fold enriched in 130 HLHS patients compared to 861 controls. This evidence concerns the gene LRP2 and hypoplastic left heart syndrome.